secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2024-03-08T23:59:59+00:00
Accession:  0001683168-24-001399
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals increases ATM offering capacity by $785,679
------------------------------------------------------------------

- Amendment No. 1 to Dec 2023 Equity Distribution Agreement with Maxim Group LLC allows sale of up to $785,679 in additional common shares.
- Shares will be sold under existing effective S-3 registration statement (File No. 333-275311) and a prospectus supplement filed March 8, 2024.
- No specific use of proceeds disclosed; prior ATM offerings typically used for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316824001399/0001683168-24-001399-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316824001399/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-001399

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer